AMGN stock · DOCS stock

AMGN vs DOCS

Amgen Inc (AMGN) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.

Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.

Doximity Inc (DOCS) is a health information services company listed on US.

Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.

Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.

AMGN currently screens at market cap $188.67B and trailing P/E 24.3. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.

Not investment advice. Open the AMGN and DOCS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons